NCT07172594

Brief Summary

This prospective randomized controlled study will be conducted to evaluate the effects of preoperative lactium on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

September 22, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2026

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

September 8, 2025

Last Update Submit

January 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of emergence agitation

    Pediatric Anesthesia Emergence Delirium scale scores will be used and a score ≥ 10 will be considered to be a diagnostic endpoint for the development of agitation. It will be assessed on arrival to the post anesthesia care unit (PACU), and every 15 min thereafter for 1 hour

    Up to 1 hour after surgery.

Secondary Outcomes (6)

  • Parental separation anxiety

    Perioperative

  • Mask Acceptance Score

    Perioperative

  • Postoperative pain

    Up to 1 hour after surgery.

  • Total dose of rescue fentanyl

    Up to 1 hour after surgery.

  • Pediatric Anesthesia Emergence Delirium scale scores

    Up to 1 hour after surgery.

  • +1 more secondary outcomes

Study Arms (2)

Lactium group

EXPERIMENTAL

cases will receive preoperative lactium, Lentra sachet (containing 150 mg Lactium) will be totally dissolved in 100 ml water and 50 ml will be given to cases, 2 hours before surgery.

Drug: Lactium

Control group

PLACEBO COMPARATOR

cases will receive 50 ml water added to it powdered vanilla flavor, 2 hours before surgery.

Other: Placebo control

Interventions

Lentra sachet (containing 150 mg Lactium) will be totally dissolved in 100 ml water and 50 ml will be given to cases, 2 hours before surgery.

Lactium group

50 ml water added to it powdered vanilla flavor will be given to cases 2 hours before surgery.

Control group

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Both gender
  • to 7 years age
  • American Society of Anesthesiologists (ASA) Physical Status I or II
  • Scheduled for adenotonsillectomy surgery under sevoflurane anesthesia

You may not qualify if:

  • Parents declined to participate in the trial
  • Children with behavioral changes; neurological or psychiatric diseases
  • Physical or developmental delay
  • Sedative or anticonvulsant medication
  • Pre-existing renal or cardiovascular disease, bone disease, or gastrointestinal disorders
  • History of lactose intolerance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Gharbia Governorate, 31527, Egypt

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double blinded
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesiology, surgical intensive care and pain medicine

Study Record Dates

First Submitted

September 8, 2025

First Posted

September 15, 2025

Study Start

September 22, 2025

Primary Completion

January 8, 2026

Study Completion

January 8, 2026

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will be available upon a reasonable request from the corresponding author after the end of the study for 1 year
Access Criteria
The data will be available upon a reasonable request from the corresponding author

Locations